Personalised home hazard assessments and interventions will help to prevent older and at-risk people from suffering from falls, according to new NICE guideline ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

Suggested remit: To appraise the clinical and cost effectiveness of tolebrutinib within its marketing authorisation for treating non-relapsing secondary progressive multiple sclerosis.

You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments. You must make your comments ...

why there is a need for the guideline the areas the guideline will and will not cover what it intends to achieve. A draft scope is provided to organisations with an interest in the topic (known as ...

Suggested remit: To appraise the clinical and cost effectiveness of Sasanlimab with BCG within its marketing authorisation for treating bladder cancer.

A list of downloadable documents created during development.

For further information on the guideline development process, please see how we develop NICE guidelines ...

A list of downloadable documents created during development.